MedPath
HSA Approval

WEISEN-U TABLET

SIN09280P

WEISEN-U TABLET

WEISEN-U TABLET

April 2, 1997

KIN FUNG WEISEN-U SINGAPORE PTE. LIMITED.

KIN FUNG WEISEN-U SINGAPORE PTE. LIMITED.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKIN FUNG WEISEN-U SINGAPORE PTE. LIMITED.
Licence HolderKIN FUNG WEISEN-U SINGAPORE PTE. LIMITED.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

**Dosage** Adults shall take 1 tablet 3 times a day after meals.

ORAL

Medical Information

**Indications** Hyperacidity, heartburn, feeling of discomfort in the stomach, feeling of fullness in the stomach, heaviness in the stomach, heaviness in the chest, belching (burping), nausea (retching, stomach nausea, hangovers and drunken retching, etc.) over-drinking, stomach pain, promotion of digestion, indigestion, anorexia, over-eating.

A02BX04

methiosulfonium chloride

Manufacturer Information

KIN FUNG WEISEN-U SINGAPORE PTE. LIMITED

Jean-Marie Pharmacal Co Ltd

Active Ingredients

ALUMINIUM HYDROXIDE (DRIED GEL)

192 mg

Aluminum hydroxide

BIODIASTASE 2000

25 mg

T-2000

METHYLMETHIONINE SULFONIUM CHLORIDE

25 mg

Documents

Package Inserts

C210302-A2_WeisenU-SGPInsertAmendment-Eng_09032021-V1.jpg

Approved: May 14, 2021

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

WEISEN-U TABLET - HSA Approval | MedPath